Atlas Trials

RRISC Study: Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent.

Clinical trial NCT00263263 · COMPLETED

Trial details

NCT number
NCT00263263
Sponsor
Antwerp Cardiovascular Institute Middelheim
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Stable AnginaUnstable AnginaCoronary Artery DiseaseSaphenous Vein Graft Disease
Start date
2003-09-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.